Madhu Gill
Family · Hagerstown, MDNPI 1053997734
Payments from drug & device makers
Across 74 payments — averaging $43.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$574
- AstraZeneca$398
- Teva Pharmaceuticals USA, Inc.$381
- GSK$355
- Novo Nordisk$350
- Axsome Therapeutics, Inc.$249
- plus $882 from 13 others
What the payments were for
- Food & beverage$3,179100%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 6 | $574 |
| AstraZeneca | 6 | $398 |
| Teva Pharmaceuticals USA, Inc. | 6 | $381 |
| GSK | 9 | $355 |
| Novo Nordisk | 20 | $350 |
| Axsome Therapeutics, Inc. | 2 | $249 |
| Lilly USA, LLC | 3 | $160 |
| Daiichi Sankyo Inc. | 1 | $108 |
| Otsuka America Pharmaceutical, Inc. | 1 | $104 |
| Amgen | 1 | $102 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $91 |
| Bayer | 3 | $66 |
| Tactile Systems Technology Inc | 3 | $66 |
| Lundbeck LLC | 2 | $52 |
| Merck | 2 | $44 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Alkermes, Inc. | 1 | $25 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,188 in reported general payments places this provider in the 85th percentile of 2,843 family providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 53 | $60,814 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 66 | $45,837 |
| FarxigaDapagliflozin Propanediol | 49 | $36,949 |
| EliquisApixaban | 35 | $28,155 |
| JanuviaSitagliptin Phosphate | 15 | $19,935 |
| TrulicityDulaglutide | 11 | $13,907 |
| Tresiba Flextouch U-200Insulin Degludec | 13 | $11,815 |
| JardianceEmpagliflozin | 12 | $9,267 |
| JanumetSitagliptin Phos/Metformin Hcl | 12 | $7,091 |
| Azelastine Hcl | 80 | $2,975 |
| Atorvastatin Calcium | 227 | $2,712 |
| Duloxetine Hcl | 29 | $2,000 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 82 | $1,700 |
| Gabapentin | 95 | $1,394 |
| Potassium Chloride | 59 | $1,304 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $350 | $60,81453 claims |
| GSKTrelegy Ellipta | $355 | $45,83766 claims |
| AstraZenecaFarxiga | $398 | $36,94949 claims |
| MerckJanuvia, Janumet | $44 | $27,02727 claims |
| Lilly USA, LLCTrulicity | $160 | $13,90711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,843 family providers in Maryland.
Other family in Hagerstown
- Ariana ChaoLutherville$727K
- Erika HoffmanPotomac$226K
- Caroline MansySalisbury$106K
- Hazel Jones-ParkerBaltimore$96K
- Brittany WilsonBaltimore$88K
- Meredith SagalHunt Valley$82K
- Sharon Dudley-BrownBel Air$67K
- Joy MaulikSalisbury$47K
- Kristin AttiogbeChevy Chase$42K
- Sametta SanyaoluFulton$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.